Abstract

A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets

Author(s): Rice Stephen P

Issue: Mar/Apr 2002 - Dermatologic Compounding

Page(s): 120-122

Download in electronic PDF format for $75
  • A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Page 1
  • A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Page 2
  • A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Page 3

Abstract

In this article, the authors list medications available in the United States that require specific containers and/or administration sets. One table includes medications that sorb to polyvinyl chloride containers and tubing; another lists medications that leach the plasticizer diethylhexyl phthalate from diethylhexyl phthalate-plasticized polyvinyl chloride bags and/or tubing to an extent that exceeds the target range of 20 micrograms/kilogram/day. The authors conclude that pharmacists practicing in a demanding intravenous admixture setting should review medication preparation guidelines for suitable diluents, volumes required for reconstitution, compatible solutions, final admixture volumes and rates of infusion. As new parenteral drug entities are introduced into the marketplace, pharmacists must select the most suitable infusion containers to provide optimal and safe parenteral therapy.

Related Keywords

  • Parenteral admixtures, percent of drugs sorbed to containers

Related Categories

  • INFUSION
  • PARENTERALS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2002
Pg. 120-122
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets
Author(s): Rice Stephen P
Jul/Aug 2021
Pg. 311-317
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Author(s): Allen Loyd V Jr
Nov/Dec 2020
Pg. 473-478
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Author(s): Allen Loyd V Jr
May/Jun 2023
Pg. 223-229
Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Author(s): Allen Loyd V Jr
May/Jun 2021
Pg. 222-229
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Author(s): Allen Loyd V Jr
Jul/Aug 1999
Pg. 303
Parenteral Admixture with Y-Site Administration
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 454-461
How to Qualify Container Closure Systems for Intended Use, Part 1
Author(s): Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
Sep/Oct 2007
Pg. 426-432
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion
Author(s): Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
Jan/Feb 2021
Pg. 52-61
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Author(s): Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Sep/Oct 2008
Pg. 463-466
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration
Author(s): Shields David E, Aclan Jennifer, Szatkowski Aaron
May/Jun 2022
Pg. 219-228
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Author(s): Allen Loyd V Jr
Sep/Oct 2020
Pg. 397-402
Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications
Author(s): Allen Loyd V Jr
Jan/Feb 1997
Pg. 54-59
Effect of Fat Emulsion and Supersaturation in Parenteral Nutrition Admixtures
Author(s): Fausel Christopher A, Newton David W, Driscoll David F, Allen Loyd V Jr
May/Jun 1997
Pg. 165-167
Parenteral Admixture Incompatibilities:An Introduction
Author(s): Allen Loyd V Jr
Sep/Oct 1997
Pg. 356-358
Compatibility of Warfarin Sodium with Selected Drugs and Large-Volume Parenteral Solutions
Author(s): Martinez Juan F, Trissel Lawrence A, Gilbert Doward L Jr
Mar/Apr 2003
Pg. 114-116
Autoclaves for the Sterilization of Compounded Parenteral Products
Author(s): Rahe Hank
Jan/Feb 2020
Pg. 14-19
How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems
Author(s): Vaughn Stacey R, Radwick Allison
Nov/Dec 2019
Pg. 478-482
Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Author(s): Allen Loyd V Jr